- Select Medical press release ( NYSE: SEM ): Q3 GAAP EPS of $0.21 misses by $0.24 .
- Revenue of $1.57B (+2.6% Y/Y) beats by $10M .
- Outlook :
- Select Medical reaffirms its 2022 business outlook. Select Medical continues to expect consolidated revenue to be in the range of $6.25 billion to $6.40 billion for the full year of 2022. Consensus $6.34B.
- Select Medical is also reaffirming its previously issued three-year compound annual growth rate target for revenue only, which is expected to be in the range of 4% to 6% for 2021 through 2023.
For further details see:
Select Medical GAAP EPS of $0.21 misses by $0.24, revenue of $1.57B beats by $10M